FUND+ PEOPLE INVESTMENT STRATEGY PORTFOLIO YOUR PROJECT NEWS CONTACT US FOSTERS INNOVATION BY INVESTING IN LIFE SCIENCES Our Mission Fund+ is an open-ended Fund for long term equity investment in innovative Life Sciences companies with a focus on Belgium. We want to create sustainable shareholders value, contribute to the development of a leadership position in the Life Sciences sector and generate a tangible, beneficial societal impact. News Recent Posts ONA Therapeutics Appoints Dr Michel Detheux as Independent Chair to Board of Directors December 2, 2021 Confo Therapeutics Enters Collaborative Agreement with Regeneron November 30, 2021 Immunic, Inc. Announces Enrollment of First Patient in its Phase 3 ENSURE Program of vidofludimus calcium (IMU-838) in Relapsing Multiple Sclerosis November 22, 2021 Contact us Address: Groot Begijnhof 60 3000 Leuven Belgium Phone: +32 (0)16 90 50 00 Email: info@fundplus.be Recent Articles ONA Therapeutics Appoints Dr Michel Detheux as Independent Chair to Board of Directors Confo Therapeutics Enters Collaborative Agreement with Regeneron Immunic, Inc. Announces Enrollment of First Patient in its Phase 3 ENSURE Program of vidofludimus calcium (IMU-838) in Relapsing Multiple Sclerosis © 2019 FUND+- ALL RIGHTS RESERVED. | We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPTRead More